Peter Blume-Jensen

President and CEO at Acrivon Therapeutics, Inc.

CIK: 1781174

Total trades

Buys

Sells

May 21, 2026

Last trade

Date	Stock	Type	Shares	Value
May 21, 2026	ACRVAcrivon Therapeutics, Inc.	Sell	13,729	$25K
May 18, 2026	ACRVAcrivon Therapeutics, Inc.	Buy	46,167	–
May 18, 2026	ACRVAcrivon Therapeutics, Inc.	Buy	14,227	–
May 18, 2026	ACRVAcrivon Therapeutics, Inc.	Buy	9,366	–
May 18, 2026	ACRVAcrivon Therapeutics, Inc.	Buy	9,366	–
May 18, 2026	ACRVAcrivon Therapeutics, Inc.	Buy	9,366	–
May 18, 2026	ACRVAcrivon Therapeutics, Inc.	Buy	9,366	–
May 18, 2026	ACRVAcrivon Therapeutics, Inc.	Buy	9,366	–
May 18, 2026	ACRVAcrivon Therapeutics, Inc.	Buy	9,366	–
May 18, 2026	ACRVAcrivon Therapeutics, Inc.	Buy	9,366	–
May 18, 2026	ACRVAcrivon Therapeutics, Inc.	Buy	180,095	–
May 18, 2026	ACRVAcrivon Therapeutics, Inc.	Buy	72,706	–
May 18, 2026	ACRVAcrivon Therapeutics, Inc.	Buy	72,981	–
May 18, 2026	ACRVAcrivon Therapeutics, Inc.	Buy	38,584	–
May 18, 2026	ACRVAcrivon Therapeutics, Inc.	Buy	49,830	–
May 18, 2026	ACRVAcrivon Therapeutics, Inc.	Buy	38,817	–
May 14, 2026	ACRVAcrivon Therapeutics, Inc.	Sell	1,253	$2K
May 14, 2026	ACRVAcrivon Therapeutics, Inc.	Sell	490	$940.8
May 14, 2026	ACRVAcrivon Therapeutics, Inc.	Sell	613	$1K
May 14, 2026	ACRVAcrivon Therapeutics, Inc.	Sell	404	$775.68
May 14, 2026	ACRVAcrivon Therapeutics, Inc.	Sell	184	$353.28
May 14, 2026	ACRVAcrivon Therapeutics, Inc.	Sell	99	$190.08
Apr 22, 2026	ACRVAcrivon Therapeutics, Inc.	Buy	3,888,888	$7.0M
Apr 17, 2026	ACRVAcrivon Therapeutics, Inc.	Sell	558	$993.24